Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Department of Neurology, Chiba Aoba Municipal Hospital, Chiba, Japan.
BMC Neurol. 2024 Jan 2;24(1):9. doi: 10.1186/s12883-023-03511-0.
Familial encephalopathy with neuroserpin inclusion bodies (FENIB) is a rare genetic disorder characterized by progressive cognitive decline and myoclonic epilepsy, caused by pathogenic variants of SERPINI1. We reported a case of genetically confirmed FENIB with de novo H338R mutation in the SERPINI1, in which frontal deficits including inattention and disinhibition, and relevant atrophy in the vmPFC on brain MRI were observed in the early stage of the disease.
A 23-year-old Japanese man presented with progressive inattention and disinhibition over 4 years followed by myoclonic epilepsy. The whole-genome sequencing and filtering analysis showed de novo heterozygous H338R mutation in the SERPINI1, confirming the diagnosis of FENIB. Single-case voxel-based morphometry using brain magnetic resonance imaging obtained at the initial visit revealed focal gray matter volume loss in the ventromedial prefrontal cortices, which is presumed to be associated with inattention and disinhibition.
Frontal deficits including inattention and disinhibition can be the presenting symptoms of patients with FENIB. Single-case voxel-based morphometry may be useful for detecting regional atrophy of the frontal lobe in FENIB. Detecting these abnormalities in the early stage of disease may be key findings for differentiating FENIB from other causes of progressive myoclonic epilepsy.
神经丝氨酸蛋白酶抑制剂 1 相关包涵体脑腱病(FENIB)是一种罕见的遗传性疾病,其特征是进行性认知能力下降和肌阵挛性癫痫,由 SERPINI1 的致病性变异引起。我们报告了一例基因确诊的 FENIB 病例,该病例中 SERPINI1 存在新发生的 H338R 突变,在疾病的早期阶段观察到额区缺陷,包括注意力不集中和抑制障碍,以及相关的 vmPFC 脑 MRI 萎缩。
一名 23 岁的日本男性,在 4 年多的时间里出现进行性注意力不集中和抑制障碍,随后出现肌阵挛性癫痫。全基因组测序和过滤分析显示 SERPINI1 中存在新发生的杂合 H338R 突变,从而确诊为 FENIB。在首次就诊时进行的单病例体素形态计量学分析显示,腹内侧前额皮质存在局灶性灰质体积丢失,这可能与注意力不集中和抑制障碍有关。
包括注意力不集中和抑制障碍在内的额叶缺陷可能是 FENIB 患者的首发症状。单病例体素形态计量学可能有助于检测 FENIB 患者额叶的区域性萎缩。在疾病的早期阶段检测到这些异常可能是将 FENIB 与其他进行性肌阵挛性癫痫病因区分开来的关键发现。